Genetic analysis finds no causal link between cannabis use and type 2 diabetes risk
A Mendelian randomization study using genetic data from nearly one million people found no evidence that cannabis use causes type 2 diabetes.
Quick Facts
What This Study Found
Using genetic variants as proxies for cannabis use, researchers found no causal effect of either lifetime cannabis use (OR 1.00, 95% CI 0.93-1.09) or cannabis use disorder (OR 1.03, 95% CI 0.99-1.08) on type 2 diabetes risk.
Key Numbers
184,765 participants for lifetime cannabis use analysis; 2,387 cases/48,985 controls for cannabis use disorder; 74,124 cases/824,006 controls for type 2 diabetes; OR = 1.00 (95% CI 0.93-1.09) for lifetime use
How They Did This
Two-sample Mendelian randomization using 19 genetic variants for lifetime cannabis use and 14 for cannabis use disorder, linked to type 2 diabetes outcomes from genome-wide association studies totaling over 900,000 participants.
Why This Research Matters
Previous observational studies have produced conflicting results about cannabis and diabetes risk. By using genetic variants as natural experiments, this study provides stronger evidence that the relationship (or lack thereof) is unlikely to be due to confounding.
The Bigger Picture
This adds to a growing body of Mendelian randomization evidence examining cannabis and metabolic health, helping separate genuine causal effects from the confounding that plagues observational studies in this area.
What This Study Doesn't Tell Us
Mendelian randomization assumes genetic variants only affect diabetes through cannabis use, which may not hold perfectly. European-ancestry population may not generalize to other groups. Cannabis use disorder had a relatively small case sample.
Questions This Raises
- ?Could specific cannabinoids (THC vs CBD) have different metabolic effects not captured by overall cannabis use?
- ?Does the route of administration or frequency of use matter for metabolic outcomes?
- ?What about type 1 diabetes?
Trust & Context
- Key Stat:
- OR = 1.00 for lifetime cannabis use and type 2 diabetes (no effect)
- Evidence Grade:
- Mendelian randomization with large sample sizes provides stronger causal inference than observational studies
- Study Age:
- Published in 2021 using genome-wide association study data from European-ancestry populations.
- Original Title:
- Cannabis use does not impact on type 2 diabetes: A two-sample Mendelian randomization study.
- Published In:
- Addiction biology, 26(6), e13020 (2021)
- Authors:
- Baumeister, Sebastian-Edgar(2), Nolde, Michael(2), Alayash, Zoheir, Leitzmann, Michael, Baurecht, Hansjörg, Meisinger, Christa
- Database ID:
- RTHC-02994
Evidence Hierarchy
Watches what happens naturally without intervening.
What do these levels mean? →Frequently Asked Questions
Does cannabis cause type 2 diabetes?
This genetic study found no evidence of a causal link. The odds ratio was exactly 1.00, meaning cannabis use showed no effect on diabetes risk in either direction.
How is this different from previous studies?
Unlike observational studies that can be confounded by lifestyle factors, this Mendelian randomization study used genetic variants as natural experiments, providing stronger evidence about causation.
Read More on RethinkTHC
- cannabis-cardiovascular-heart-risk-stroke
- cannabis-heart-cardiovascular-risk
- coughing-up-stuff-after-quitting-weed
- lung-recovery-after-quitting-smoking-weed
- lung-recovery-quitting-weed
- quitting-weed-female-hormones
- quitting-weed-weight-gain-loss-diet-appetite
- sex-after-quitting-weed
- weed-DUI-driving-impaired-cannabis-laws
- weed-acne-skin
- weed-fertility-sperm
- weed-gut-digestion-problems
- weed-heart-health
- weed-testosterone-levels
Cite This Study
https://rethinkthc.com/research/RTHC-02994APA
Baumeister, Sebastian-Edgar; Nolde, Michael; Alayash, Zoheir; Leitzmann, Michael; Baurecht, Hansjörg; Meisinger, Christa. (2021). Cannabis use does not impact on type 2 diabetes: A two-sample Mendelian randomization study.. Addiction biology, 26(6), e13020. https://doi.org/10.1111/adb.13020
MLA
Baumeister, Sebastian-Edgar, et al. "Cannabis use does not impact on type 2 diabetes: A two-sample Mendelian randomization study.." Addiction biology, 2021. https://doi.org/10.1111/adb.13020
RethinkTHC
RethinkTHC Research Database. "Cannabis use does not impact on type 2 diabetes: A two-sampl..." RTHC-02994. Retrieved from https://rethinkthc.com/research/baumeister-2021-cannabis-use-does-not
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.